Splenic marginal zone lymphoma differential diagnosis
Splenic marginal zone lymphoma Microchapters |
Differentiating Splenic marginal zone lymphoma from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Splenic marginal zone lymphoma differential diagnosis On the Web |
American Roentgen Ray Society Images of Splenic marginal zone lymphoma differential diagnosis |
FDA on Splenic marginal zone lymphoma differential diagnosis |
CDC on Splenic marginal zone lymphoma differential diagnosis |
Splenic marginal zone lymphoma differential diagnosis in the news |
Blogs on Splenic marginal zone lymphoma differential diagnosis |
Directions to Hospitals Treating Splenic marginal zone lymphoma |
Risk calculators and risk factors for Splenic marginal zone lymphoma differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview
Splenic marginal zone lymphoma must be differentiated from other diseases such as chronic lymphocytic leukemia, follicular lymphoma, and mantle cell lymphoma.[1]
Differential Diagnosis
Splenic marginal zone lymphoma must be differentiated from other diseases such as:[1]
Differential Diagnosis | CD5 | CD10 | Cyclin-D1 |
---|---|---|---|
Splenic marginal zone lymphoma |
Negative |
Negative |
Negative |
Chronic lymphocytic leukemia |
Positive |
Negative |
Negative |
Follicular lymphoma |
Negative |
Positive |
Positive |
Mantle cell lymphoma |
Positive |
Negative |
Positive |
References
- ↑ 1.0 1.1 Splenic marginal zone lymphoma. Surveillance, Epidemiology, and End Results Program. http://seer.cancer.gov/seertools/hemelymph/51f6cf57e3e27c3994bd5327/. Accessed on January 14, 2016